Falkovia designs the clinical authority structures, decision rights, and override protocols that healthcare leadership teams need before regulatory or patient safety events force the question.
AI is embedded in clinical workflows, diagnostic support, documentation, scheduling, and revenue cycle management across healthcare systems. Much of it was adopted without formal governance approval. Some of it was never evaluated for patient safety implications. Almost none of it has documented decision authority or override protocols.
The governance gap is not theoretical. State legislatures are passing AI-specific healthcare regulations. CMS is developing AI oversight requirements. Accreditation bodies are issuing AI governance standards. And the plaintiff's bar is already building cases around AI-driven healthcare decisions that lacked documented human oversight.
The question for healthcare leadership is not whether to adopt AI. It is whether the governance architecture exists to make every AI-assisted decision in your system defensible: to your board, your regulators, your accreditors, and a jury.
Who in your organization has the documented authority to approve, restrict, or prohibit AI use in clinical workflows, diagnostics, and patient-facing operations?
When an AI-assisted clinical decision is wrong, is there a documented protocol for clinician override, and is it structurally embedded in the workflow, or dependent on individual judgment in the moment?
How many AI tools are being used across your system right now that were never formally approved, evaluated for patient safety, or documented in your governance architecture?
If a state regulator, CMS auditor, or accreditation body asked to see your AI governance documentation tomorrow, what would you hand them?
If an AI-assisted clinical decision led to a patient safety event tonight, does your organization have a documented response protocol, or would leadership be designing one in the middle of a crisis?
Complete inventory of AI tools in use across clinical, operational, and administrative domains, including tools adopted without formal governance approval.
Governance, Understanding, Authority, Reputation, and Design framework customized to your institution's regulatory and accreditation environment.
Role-by-role documentation of who holds authority to approve, restrict, override, and prohibit AI use across every institutional domain.
Documented mapping of where human clinical judgment must remain non-delegable, by system, by workflow, by risk level.
Documented protocols for clinician override of AI-assisted decisions, including escalation paths and accountability structures.
Board-ready AI governance charter defining oversight responsibilities, reporting requirements, and fiduciary accountability structures.
Baseline mapping of governance architecture to current state AI legislation, CMS requirements, Joint Commission standards, and applicable federal frameworks.
AI-specific privacy and data governance protocols aligned with HIPAA requirements and institutional data handling standards.
Documented protocol for AI-related patient safety events, regulatory inquiries, and public-facing incidents with named accountability and response timelines.
Phased implementation plan with accountability assignments, milestones, and governance maturity benchmarks.
Falkovia's G.U.A.R.D. Framework™ produces healthcare AI governance that holds under Joint Commission, CMS, and HIPAA scrutiny. Built by a forensic psychologist and founding university president, structured to transfer to your leadership team at close. Architecture your organization owns from day one. Built to hold.
No dependency. That is the design.Accountable for institutional AI governance and responsible for ensuring the organization's AI adoption does not create regulatory, legal, or patient safety exposure that reaches the board.
Responsible for clinical quality and patient safety across AI-assisted workflows, diagnostics, and documentation, and accountable when AI-related clinical decisions are questioned.
Managing legal exposure from AI-assisted clinical decisions, regulatory compliance obligations, and the growing landscape of state AI legislation and litigation.
Responsible for regulatory compliance, accreditation readiness, and risk management across an AI landscape that is evolving faster than most compliance frameworks can track.
Exercising fiduciary oversight of AI adoption without operational visibility into how AI is being used in clinical workflows, who approved it, or whether governance structures exist to manage it.
Five-dimension governance frame (Governance, Understanding, Authority, Reputation, Design) calibrated to clinical, regulatory, and accreditation environments.
Documented boundary where algorithmic recommendation ends and clinical judgment must remain non-delegable. Five levels of authority calibrated to risk.
Psychology-based diagnostic measuring six human variables that determine whether clinical AI initiatives succeed or stall.
Scored assessment across the five G.U.A.R.D. dimensions. Maps to Exposed, Reactive, Structured, and Architected maturity levels.
Department-by-department inventory of approved and unapproved AI in clinical and administrative workflows.
Operational template for the first ninety minutes of an AI-related clinical event. The window where governance holds or breaks.
See where your health system’s AI governance is exposed, and where to focus first.
Take the 5-minute assessmentA compliance audit tests whether you meet a defined standard. A Falkovia engagement designs the human governance architecture underneath that standard: who holds clinical override authority, where the Human Authority Line is drawn for each AI-assisted workflow, and how your organization responds in the first 90 minutes of an AI-related patient safety event. Compliance frameworks assume the architecture exists. Falkovia builds it.
No. Most engagements begin after AI is already in active clinical use. The Shadow AI Audit and decision authority mapping are designed precisely for organizations whose AI footprint has outpaced their governance architecture. The earlier the governance work begins, the less reactive it has to be when regulators or accreditors ask the question.
G.U.A.R.D. stands for Governance, Understanding, Authority, Reputation, and Design. It is one of several structured instruments Falkovia applies in healthcare engagements. The full assessment includes the AI Governance Maturity Scorecard™, the AI Adoption Risk Index™, a Shadow AI Audit, and the AI Governance Framework for Hospital Boards, alongside a 50+ question diagnostic mapped to NIST AI RMF, ISO/IEC 42001, and the EU AI Act. Together they produce a documented governance architecture customized to your organization's regulatory environment, accreditation status, and current AI exposure.
Both. The governance architecture is sector-specific, not size-specific. Academic medical centers carry additional research and IRB considerations; community systems often carry more shadow AI exposure because deployment moved faster than central oversight. The engagement is scoped to the organization's actual governance landscape.
The architecture is designed to integrate with, not replace, existing medical staff governance. Falkovia maps where AI-related clinical decisions intersect with credentialing, peer review, and quality oversight structures, and produces governance documentation that medical staff leadership can adopt without rewriting their bylaws.
Yes. Multi-state systems are one of the most common engagement profiles. The regulatory mapping is built into the engagement, including Texas TRAIGA, Colorado's AI Act, and the growing patchwork of state-level healthcare AI legislation. The governance architecture is designed to hold across the strictest applicable standard.
Not the committee, and not the vendor. Accountability sits with the named people inside the health system who hold authority over the deployment: who approved the tool, who monitors its outputs, and who can override or pause it in a clinical moment. A vendor contract can cap the vendor's exposure well below the cost of a single adverse event, and the health system's name stays on the outcome. Falkovia draws the Human Authority Line for each clinical workflow so that authority and accountability are documented and assigned to real people.
More than whether a policy exists. A board should be able to name the single executive accountable for AI oversight across the institution, and produce a current inventory of every AI tool in use, including the ones embedded in vendor platforms. It should know which systems are classified as high risk, whether a documented Human Authority Line exists for each one, and who would respond if a high-risk system produced a significant error tomorrow. It should be able to say who can approve a new AI tool, who can expand its scope, and who can shut one down, and whether an AI-influenced clinical or operational decision can be reconstructed if a regulator or plaintiff asks. And it should know whether the hospital is measuring AI in patient and clinician trust, not only in efficiency, and whether its governance is built to evolve rather than sit as a static document. Together, these questions show whether the hospital's AI governance is operational or only documented.
Every engagement begins with a confidential conversation about what your health system actually needs.
Start a Confidential Conversation